Paper Details

  1. Home
  2. Paper Details

Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm.

Author: BorensteinD G, LacksS, WieselS W

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Cyclobenzaprine and naproxen combination therapy was more effective than naproxen alone for treating acute low back pain with associated muscle spasm. It provided greater relief from muscle spasm and tenderness and faster resolution of functional deficits and pain.
Paper Details　
Original Abstract of the Article :
Two groups of 20 patients each, with mild to moderate acute low back pain with associated muscle spasm of ten days' duration or less, were treated with a combination of cyclobenzaprine and naproxen or naproxen alone in a randomized, 14-day open-label trial. Cyclobenzaprine was added to the naproxen ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2141299

データ提供：米国国立医学図書館（NLM）

A Painful Back: A Journey Through the Desert of Back Pain

This research explores the complex landscape of acute low back pain, a common ailment that can significantly impact daily life. The authors conducted a randomized, controlled trial to assess the effectiveness of combining cyclobenzaprine (a muscle relaxant) with naproxen (a nonsteroidal anti-inflammatory drug) for treating low back pain and muscle spasm. It's like embarking on a journey through the desert of back pain, seeking relief and restoring mobility.

The Path to Relief: Choosing the Right Oasis

The results revealed that the combination therapy yielded promising outcomes, reducing muscle spasm and tenderness, and enhancing mobility. This suggests that combining these medications could be an effective strategy for alleviating acute low back pain. It's like finding a well-stocked oasis in the desert of pain, providing much-needed relief.

Navigating the Desert of Back Pain

This research provides valuable insights into the treatment of low back pain, a pervasive health concern. It highlights the potential benefits of combining muscle relaxants with anti-inflammatory drugs. Remember to consult with your healthcare provider before starting any new treatment plan and embark on your journey through the desert of back pain with informed guidance.

Dr. Camel's Conclusion

This study offers a valuable roadmap for navigating the often-challenging desert of low back pain. While the combination therapy showed promising results, it's crucial to remember that each individual is unique and the optimal treatment may vary. Always seek expert advice and personalize your journey through this challenging terrain.

Date :
  1. Date Completed 1990-07-24
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2141299

DOI: Digital Object Identifier

2141299

Related Literature

Article Analysis
・Side Effects of cyclobenzaprine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.